英文名稱
6-Desacetyl-6-bromo-N-Boc Palbociclib
4-[6-[(6-溴-8-環戊基-7,8-二氫-5-甲基-7-氧代吡啶并[2,3-d]嘧啶-2-基)氨基]-3-吡啶
純度
No Data Available
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
6-Desacetyl-6-bromo-N-Boc Palbociclib is an impurity of Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one (B682195), which is used to prepare pyridino[2,3-d]pyrimidin-7(8H)-one derivatives as CDK4 and/or CDK6 inhibitors useful in the treatment of diseases.